Advisory Research Inc Legend Biotech Corp Transaction History

Advisory Research Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $280,935 - $340,272	-4,448 Reduced 46.43%	5,131 $344,000
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $163,738 - $265,385	3,538 Added 58.57%	9,579 $661,000
Q1 2023 May 12, 2023	BUY	$43.42 - $57.37 $3,039 - $4,015	70 Added 1.17%	6,041 $291,000
Q4 2022 Feb 13, 2023	BUY	$38.8 - $55.46 $19,400 - $27,730	500 Added 9.14%	5,971 $298,000
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $76,300 - $114,200	-2,000 Reduced 26.77%	5,471 $223,000
Q2 2022 Aug 17, 2022	BUY	$33.54 - $55.0 $250,577 - $410,905	7,471 New	7,471 $411,000

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.